Ottonomy raises Rs 40.6 crore to take hospital delivery robots global

Representative image: herbert11timtim / Pixabay
Ottonomy, the delivery-robot maker led by Ritukar Vijay, raised about Rs 40.6 crore ($4.2 million) in a post-seed round reported on 4 November 2026.
What Happened
Ottonomy, a company that builds self-driving delivery robots for hospitals and industrial sites, has raised about Rs 40.6 crore, or roughly $4.2 million, in a post-seed funding round, according to start-up funding reports published on Wednesday, 4 November 2026. Japan-based Enrission India Capital took part in the round. The company, led by chief executive Ritukar Vijay, plans to use the money to expand abroad, mainly in healthcare and industrial facilities, where it pitches its robots as an answer to staff shortages.
Key Facts
- Round size: about Rs 40.6 crore (around $4.2 million), described as a post-seed round.
- Investor named: Enrission India Capital, a Japan-based fund; reports differ on whether any investor led the round, and the lead has not been confirmed.
- Product: the Ottobot, a robot the company describes as Level-4 autonomous, meaning it can move on its own without a human driver within the settings it is built for, such as hospital corridors, lifts, pavements and service roads.
- Hospital use: Ottonomy and Arrive AI run a medical delivery system using Ottobots at Hancock Regional Hospital in Greenfield, Indiana, in the United States.
- Software: in February 2026, at the India AI Impact Summit in New Delhi, the company presented Ottumn.AI, a cloud platform meant to coordinate robots, drones and building systems.
- Use of funds: wider deployment in healthcare and industrial sites outside India, according to the reports on the round.
- Patents: Vijay has said the company holds 24 patents from 29 filings.
Why It Matters
Robots that carry things inside buildings are one of the quieter corners of the automation boom. A hospital moves medicines, lab samples, linen and meals around the clock, and nurses and porters often do the walking. Companies like Ottonomy sell the idea that a robot can take over those trips, so that staff spend more of their shift with patients. Vijay has put it plainly: one of the main problems the company is trying to solve with its robots is labour shortages.
Ottonomy is also a useful case for Indian founders who want to build hardware for global buyers. The company showed its "made in India" delivery system at the India AI Impact Summit in February, while its best-known deployment is at a hospital in the US state of Indiana. Reports describe its base differently: some call it California-based, others New York-based, and others stress its Indian roots. That mix is common for start-ups with Indian founders that sell into American and European markets while keeping engineering links in India.
The size of the round is modest by robotics standards. Building and maintaining physical machines costs far more than shipping software, so a $4.2 million post-seed round is best read as money to prove that deployments can grow, rather than to scale a fleet. Investors in this field look closely at how many robots are working in paying sites and how often they need a human to step in, figures Ottonomy has not published with this round.
Peepals calculation: The two reported figures for the round, Rs 40.6 crore and $4.2 million, imply an exchange rate of about Rs 96.7 to the dollar (406,000,000 ÷ 4,200,000). On the company's own patent figures, 24 granted out of 29 filed is a grant share of about 83% (24 ÷ 29). Our calculation from the reported figures.
| Item | Detail |
|---|---|
| Company | Ottonomy (Ottonomy.IO) |
| Round | Post-seed, about Rs 40.6 crore ($4.2 million) |
| Investor named | Enrission India Capital (Japan-based) |
| Main product | Ottobot delivery robot |
| Software platform | Ottumn.AI |
Impact
Short-term: The money gives Ottonomy room to add hospital and factory customers abroad and to grow its engineering team. The company's existing hospital deployment in Indiana will be the reference most buyers look at.
Long-term: If hospitals and plants keep struggling to hire, demand for indoor delivery robots could rise. Whether Ottonomy captures that demand will depend on how reliably its robots handle lifts, doors and crowded corridors at scale, and on how its software platform links robots with drones and other machines.
Who is affected: Hospital staff and managers looking for help with routine deliveries; industrial operators with long internal supply runs; Indian engineers and founders working on robotics; and investors, including Japanese funds, looking at India-linked deep-tech start-ups.
Key Takeaway
Ottonomy's roughly Rs 40.6 crore post-seed round, with Japan's Enrission India Capital, is meant to take its Ottobot hospital delivery robots to more sites abroad.
Questions and Answers
How much did Ottonomy raise and from whom?
Ottonomy raised about Rs 40.6 crore, or roughly $4.2 million, in a post-seed round reported on 4 November 2026. Japan-based Enrission India Capital took part; a lead investor has not been confirmed.
What is an Ottobot?
An Ottobot is Ottonomy's delivery robot. The company says it can move on its own through hospital corridors, lifts, pavements and service roads, avoiding obstacles without a human controlling it.
Where are Ottonomy's robots used?
Its best-known deployment is a medical delivery system run with Arrive AI at Hancock Regional Hospital in Greenfield, Indiana, in the United States. The new money is meant for more healthcare and industrial sites abroad.
Who runs Ottonomy?
Ottonomy is led by its founder and chief executive, Ritukar Vijay, who says the company's robots are aimed at labour shortages in hospitals and industry.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
By Elena D’Souza, Startups & Innovation CorrespondentCovers Start-ups & Opportunities and more for Peepals Global. All stories by Elena D’Souza
Get the day's stories in your inbox
Peepals Weekly: the week decoded, free. One email a week, unsubscribe in one click.
Elena D’Souza is a pen name of the Peepals Global Editorial Team, which researches, fact-checks and publishes every story. The portrait is an illustration.









